松井勝彦 Matsui Katsuhiko (准教授)    - 業績 -


主な原著論文(2000年以降)

タイトルをクリックするとPubMedにジャンプします

Effects of macrolide antibiotics on Th1 cell and Th2 cell development mediated by Langerhans cells:
Matsui K, Tamai S and Ikeda R.
J. Pharm. Pharm. Sci. 19, 357-366 (2016)

Betamethasone, but not tacrolimus, suppresses the development of Th2 cells mediated by Langerhans cell-like dendritic cells:
Matsui K, Tamai S and Ikeda R.
Biol. Pharm. Bull. 39, 1220-1223 (2016)

Langerhans cell-like dendritic cells stimulated with an adjuvant direct the development of Th1 and Th2 cells in vivo:
Matsui K, Mori A and Ikeda R.
Clin. Exp. Immunol. 182, 101-107 (2015)

CCL17 production by mouse Langerhans cells stimulated with Staphylococcus aureus cell wall components:
Matsui K, Tofukuji S and Ikeda R.
Biol. Pharm. Bull. 38, 317-320 (2015)

Peptidoglycan in combination with muramyldipeptide synergistically induces an interleukin-10-dependent T helper 2-dominant immune response:
Matsui K and Ikeda R.
Microbiol. Immunol. 58, 260-265 (2014)

Peptidoglycan-induced T helper 2 immune response in mice involves interleukin-10 secretion from Langerhans cells:
Matsui K and Nishikawa A.
Microbiol. Immunol. 57, 130-138 (2013)

Peptidoglycan from Staphylococcus aureus induces Th2 immune response in mice:
Matsui K and Nishikawa A.
J. Investig. Allergol. Clin. Immunol. 22, 80-86 (2012)

Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin:
Matsui K and Nishikawa A.
J. Investig. Allergol. Clin. Immunol. 21, 354-362 (2011)

Inhibitory effects of Schefflera leucantha extract on production of allergic mediators by Langerhans cells and mast cells:
Matsui K, Wirotesangthong M, Thanakijcharoenpath W, Mungmee C and Nishikawa A.
J. Investig. Allergol. Clin. Immunol. 20, 463-468 (2010)

Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells:
Matsui K, Wirotesangthong M and Nishikawa A.
Int. Arch. Allergy Immunol. 149, 167-172 (2009)

Peptidoglycan from Staphylococcus aureus induces IL-4 production from murine spleen cells through an IL-18-dependent  mechanism:
Matsui K, Wirotesangthong M and Nishikawa A.
Int. Arch. Allergy Immunol. 146, 262-266 (2008)

Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin:
Matsui K, Wirotesangthong M and Nishikawa A.
Clin. Exp. Allergy 37, 615-622 (2007)

Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen:
Matsui K and Nishikawa A.
Int. Arch. Allergy Immunol. 139, 271-278 (2006)

Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis  of mice:
Matsui K and Nishikawa A.
Clin. Exp. Allergy 35, 382-387 (2005)

Effects of the macrolide antibiotic, midecamycin, on Staphylococcus aureus product-induced Th2 cytokine response in patients  with atopic dermatitis:
Matsui K and Nishikawa A.
J. Interferon Cytokine Res. 24, 197-201 (2004)

Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific IgE production in mice:
Matsui K and Nishikawa A.
Clin. Exp. Allergy 33, 842-848 (2003)

Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen:
Matsui K and Nishikawa A.
Clin. Exp. Allergy 32, 783-788 (2002)

Lipopolysaccharide of Haemophilus influenzae induces interleukin-5 mRNA expression in human peripheral blood mononuclear cells:
Matsui K, Tanaka N and Nishikawa A.
J. Interferon Cytokine Res. 21, 439-443 (2001)

Comparative study of Staphylococcal aureus isolated from lesional and non-lesional skin of atopic dermatitis patients:
Matsui K, Nishikawa A, Suto H, Tsuboi R and Ogawa H.
Microbiol. Immunol. 44, 945-947 (2000)

Cell-wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis:
Matsui K, Motohashi R and Nishikawa A.
J. Interferon Cytokine Res. 20, 321-324 (2000)